Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Marburgvirus Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Marburgvirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Marburgvirus Infections and features dormant and discontinued projects.
Key Targets in the Marburgvirus Infections Pipeline Drugs Market
In the Marburgvirus Infections pipeline drugs market the key targets are Ebola virus Matrix Protein VP40, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin L1, Glycoprotein, Hepatitis A Virus Cellular Receptor 1, Interferon Alpha, Interferon Beta, Interferon Gamma, Mannosyl Oligosaccharide Glucosidase, and Marburg Virus Membrane Associated Protein VP24.
Marburgvirus Infections Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Marburgvirus Infections Pipeline Drugs Market
70 kDa Ribosomal Protein S6 Kinase Inhibitor has the highest number of pipeline products followed by Cathepsin L1 Inhibitor, Ebola virus Matrix Protein VP40 Inhibitor, Hepatitis A Virus Cellular Receptor 1 Inhibitor, Interferon Alpha Activator, Interferon Beta Activator, Interferon Gamma Activator, Mannosyl Oligosaccharide Glucosidase Inhibitor, Marburg Virus Membrane Associated Protein VP24 Inhibitor, and Na+/K+ Exchanging ATPase Inhibitor.
Marburgvirus Infections Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Marburgvirus Infections pipeline drugs market are inhalational, intramuscular, oral, nasal, intravenous, and transdermal. Inhalational has the maximum number of pipeline products.
Marburgvirus Infections Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Marburgvirus Infections Pipeline Drugs Market
The key molecule types in the Marburgvirus Infections pipeline drugs market are small molecule, recombinant vector vaccine, subunit vaccine, vaccine, monoclonal antibody, antibody, protein, and recombinant protein.
Marburgvirus Infections Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Marburgvirus Infections Pipeline Drugs Market
The major companies in the Marburgvirus Infections pipeline drugs market are Integrated BioTherapeutics Inc, Emergent BioSolutions Inc, AIkido Pharma Inc, Intervir Therapeutics, Soligenix Inc, TFF Pharmaceuticals Inc, AlphaVax Inc, ANP Technologies Inc, and Auro Vaccines LLC.
Marburgvirus Infections Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Marburgvirus Infections Pipeline Drugs Market Overview
Key Targets | Ebola virus Matrix Protein VP40, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin L1, Glycoprotein, Hepatitis A Virus Cellular Receptor 1, Interferon Alpha, Interferon Beta, Interferon Gamma, Mannosyl Oligosaccharide Glucosidase, and Marburg Virus Membrane Associated Protein VP24 |
Key Mechanisms of action | 70 kDa Ribosomal Protein S6 Kinase Inhibitor, Cathepsin L1 Inhibitor, Ebola virus Matrix Protein VP40 Inhibitor, Hepatitis A Virus Cellular Receptor 1 Inhibitor, Interferon Alpha Activator, Interferon Beta Activator, Interferon Gamma Activator, Mannosyl Oligosaccharide Glucosidase Inhibitor, Marburg Virus Membrane Associated Protein VP24 Inhibitor, and Na+/K+ Exchanging ATPase Inhibitor. |
Key Routes of Administration | Inhalational, Intramuscular, Oral, Nasal, Intravenous, and Transdermal |
Key Molecule Types | Small Molecule, Recombinant Vector Vaccine, Subunit Vaccine, Vaccine, Monoclonal Antibody, Antibody, Protein, and Recombinant Protein |
Major Companies | Integrated BioTherapeutics Inc, Emergent BioSolutions Inc, AIkido Pharma Inc, Intervir Therapeutics, Soligenix Inc, TFF Pharmaceuticals Inc, AlphaVax Inc, ANP Technologies Inc, and Auro Vaccines LLC |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Marburgvirus Infections
- The pipeline guide reviews pipeline therapeutics for Marburgvirus Infections by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Marburgvirus Infections therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Marburgvirus Infections therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Marburgvirus Infections
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Marburgvirus Infections
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Marburgvirus Infections pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
AlphaVax Inc
ANP Technologies Inc
Auro Vaccines LLC
BioCryst Pharmaceuticals Inc
Collaborations Pharmaceuticals Inc
Emergent BioSolutions Inc
Emergex Vaccines Holding Ltd
Fab’entech SA
Flow Pharma Inc
Fox Chase Chemical Diversity Center Inc
GeoVax Labs Inc
Globavir Biosciences Inc
Greffex Inc
Helix Biogen Institute
Integrated BioTherapeutics Inc
Intervir Therapeutics
Mapp Biopharmaceutical Inc
Microbiotix Inc
Phoenix Biotechnology Inc
ReVacc Biotech
Rodos BioTarget GmbH
Selva Therapeutics Inc
Soligenix Inc
TFF Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Marburgvirus Infections pipeline drugs market?
In the Marburgvirus Infections pipeline drugs market the key targets are Ebola virus Matrix Protein VP40, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin L1, Glycoprotein, Hepatitis A Virus Cellular Receptor 1, Interferon Alpha, Interferon Beta, Interferon Gamma, Mannosyl Oligosaccharide Glucosidase, and Marburg Virus Membrane Associated Protein VP24.
-
What are the key mechanisms of action in the Marburgvirus Infections pipeline drugs market?
In the Marburgvirus Infections pipeline drugs market the key mechanisms of action are 70 kDa Ribosomal Protein S6 Kinase Inhibitor, Cathepsin L1 Inhibitor, Ebola virus Matrix Protein VP40 Inhibitor, Hepatitis A Virus Cellular Receptor 1 Inhibitor, Interferon Alpha Activator, Interferon Beta Activator, Interferon Gamma Activator, Mannosyl Oligosaccharide Glucosidase Inhibitor, Marburg Virus Membrane Associated Protein VP24 Inhibitor, and Na+/K+ Exchanging ATPase Inhibitor.
-
What are the key routes of administration in the Marburgvirus Infections pipeline drugs market?
The key routes of administration in the Marburgvirus Infections pipeline drugs market are Inhalational, Intramuscular, Oral, Nasal, Intravenous, and Transdermal.
-
What are the key molecule types in the Marburgvirus Infections pipeline drugs market?
The key molecule types in the Marburgvirus Infections pipeline drugs market are small molecule, recombinant vector vaccine, subunit vaccine, vaccine, monoclonal antibody, antibody, protein, and recombinant protein.
-
What are the major companies in the Marburgvirus Infections pipeline drugs market?
In the Marburgvirus Infections pipeline drugs market the major companies are Integrated BioTherapeutics Inc, Emergent BioSolutions Inc, AIkido Pharma Inc, Intervir Therapeutics, Soligenix Inc, TFF Pharmaceuticals Inc, AlphaVax Inc, ANP Technologies Inc, and Auro Vaccines LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.